Anticoagulation monitoring during extracorporeal membrane oxygenation: is anti-factor Xa assay (heparin level) a better test?*.
Section of Critical Care Medicine Department of Pediatrics; and Division of Thrombosis Research Department of Medicine Texas Children's Hospital/Baylor College of Medicine Houston, TX Section of Critical Care Medicine Department of Pediatrics Texas Children's Hospital/Baylor College of Medicine Houston, TX Division of Transfusion Medicine & Coagulation Texas Children's Hospital/Baylor College of Medicine Houston, TX.
Trung
T
Nguyen
Matthew
M
Musick
Jun
J
Teruya
D000925:Anticoagulants / Q000008:administration & dosage*; D016903:Drug Monitoring / Q000379:methods*; D015199:Extracorporeal Membrane Oxygenation / Q000379:methods*; D015951:Factor Xa / Q000276:immunology*; D005260:Female; D006493:Heparin / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D010314:Partial Thromboplastin Time / Q000379:methods*; D014914:Whole Blood Coagulation Time / Q000379:methods*
D000925:Anticoagulants; D006493:Heparin; D015951:Factor Xa